ERBB2 and cancer: In this paper, we present a new idea for combining radionuclide therapy with magnetic hyperthermia through the application of core-shell superparamagnetic Fe3O4 covered with a 198Au layer and conjugated with trastuzumab (Tmab)—monoclonal antibody used to target the HER2 positive cancer cells.